| 1 Trastuzumab |
|---|
search
Applications
Trastuzumab Triplicate Injections on bioZen 1.8 um SEC-3
25046
Separation Mode: Size Exclusion
Size Exclusion
SEC-3
HPLC
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25046)
Column: |
Brand Name: bioZen |
Part No: |
Phase Name: SEC-3 |
System: Agilent Technologies Agilent Technologies |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.